Who has invested in Xinma Bio?

Baird Capital, Arboretum Ventures, LYZZ Capital are named among the investors backing Xinma Bio.

Xinma Bio Funding: $21M Raised, Series B (2021)

Xinma Bio funding overview

Xinma Bio has raised $21M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Xinma Bio runs through 2021; nothing later has been disclosed. Investors on record include Baird Capital, Arboretum Ventures, LYZZ Capital. 3 distinct backers are named across the disclosed rounds.

Xinma Bio at a glance

Total raised: $21M
Latest round: Series B
Latest round date: January 2021
Notable investors: Baird Capital, Arboretum Ventures, LYZZ Capital

Frequently asked about Xinma Bio funding

How much has Xinma Bio raised?: Xinma Bio has raised $21M in total disclosed funding across the rounds on record.
Who has invested in Xinma Bio?: Baird Capital, Arboretum Ventures, LYZZ Capital are named among the investors backing Xinma Bio.
What was the latest Xinma Bio funding round?: The most recent disclosed round is a Series B, announced in January 2021.
Where is Xinma Bio based?: No headquarters location is disclosed for Xinma Bio.
When did Xinma Bio last raise?: The last disclosed Xinma Bio round closed in January 2021 at Series B.

Every Xinma Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies at a similar stage.

Xinma Bio Funding: $21M Raised, Series B (2021)

Xinma Bio funding overview

Xinma Bio at a glance

Frequently asked about Xinma Bio funding

Companies related to Xinma Bio (36)

Browse related funding lists (4)